Maria Rosaria Ruocco Selected Research

Maria Rosaria Ruocco Research Topics

12	Neoplasms (Cancer) 01/2024 - 04/2013
10	Melanoma (Melanoma, Malignant) 04/2023 - 04/2013
2	Inflammation (Inflammations) 04/2023 - 06/2022
2	Neuroblastoma 10/2019 - 01/2010
2	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2013 - 01/2010
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024
1	Lymphoma (Lymphomas) 01/2024
1	Thyroid Neoplasms (Thyroid Cancer) 08/2022
1	Leukemia 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Pheochromocytoma 07/2010

3	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2023 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2015
2	Conditioned Culture MediaIBA 06/2022 - 11/2019
2	Cytochromes c (Cytochrome c)IBA 12/2020 - 04/2013
2	cdc25 PhosphatasesIBA 12/2020 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019 - 01/2018
2	CytokinesIBA 11/2019 - 01/2018
2	Diclofenac (SR 38)FDA LinkGeneric 04/2013 - 01/2010
2	Superoxide DismutaseIBA 04/2013 - 01/2010
1	Rituximab (Mabthera)FDA Link 01/2024
1	HydrogelsIBA 04/2023
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2023
1	Celecoxib (Celebrex)FDA Link 04/2023
1	ProstaglandinsIBA 04/2023
1	Indicators and Reagents (Reagents)IBA 08/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2022
1	CaspasesIBA 12/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2020
1	Antineoplastic Agents (Antineoplastics)IBA 12/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2019
1	ageritinIBA 10/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2019
1	NeurotoxinsIBA 10/2019
1	AcidsIBA 01/2019
1	Dual-Specificity PhosphatasesIBA 11/2015
1	LigandsIBA 11/2015
1	7-dehydrocholesterolIBA 05/2014
1	Cyclooxygenase InhibitorsIBA 04/2013
1	Caspase 3 (Caspase-3)IBA 04/2013
1	Caspase 9IBA 04/2013
1	Nerve Growth Factor (NGF)IBA 07/2010
1	AntioxidantsIBA 01/2010

9	Therapeutics 04/2023 - 04/2013
1	Drug Therapy (Chemotherapy) 01/2018